Program Leaders: Lewis Chodosh, MD, PhD and Angela DeMichele, MD, MSE
Since Penn's discovery of the Philadelphia Chromosome which revolutionized cancer treatment, we've had a history of groundbreaking research.
Every day our scientists learn more about the causes of breast cancer, as well as, better ways to prevent and detect breast cancer. Penn continues to be on the cutting edge of designing novel treatments for breast cancer.
We are at the forefront in a number of areas, all of which can make a difference to patients, today and in the future.
Penn's Breast Cancer Research Program is one of the few programs of its kind approved and funded by the National Cancer Institute.
Our research initiatives aimed at breast cancer prevention, risk, diagnosis, and treatment include:
As one of the nation's largest cancer research centers our investigators benefit each day from collaborations and interactions with over 400 scientists and physicians involved in the Abramson Cancer Center.